- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00460161
Acupuncture for Phantom Limb Pain
Acupuncture for Phantom Limb Pain: A Randomized, Double-Blind, Placebo/Sham - Controlled Study
Phantom pain is a common complication following limb amputation, and is thought to result from a system of pathophysiological mechanisms - peripheral, spinal, central and psychological. Treatment is primarily medical, using antidepressant and anticonvulsant medications. At present, there is no evidence-based approach for the management of phantom limb pain (PLP). Acupuncture is an ancient Chinese treatment during which thin needles (diameter 0.20-0.30mm) are inserted into various points on the skin. Studies of this treatment have found significant benefit in a number of conditions with chronic pain.
We propose a randomized, double-blind, placebo/sham -controlled study to evaluate whether acupuncture is an effective and safe modality for preventing and reducing PLP in patients following lower limb amputation. Patients requiring lower limb amputation (above-ankle) will be randomized into two groups, for real or placebo/sham acupuncture treatment. Both groups will be treated twice-weekly with a standardized (as opposed to individualized) acupuncture treatment protocol, using either true or placebo needles at sham acupuncture points, for a period of four weeks (eight treatments).
The primary outcome to be evaluated will be PLP at 4 weeks, using a site-specific numerical rating pain scale (ss-NRS). Secondary outcome measures to be evaluated are: stump pain (ss-NRS); analgesic use (Tramadol, 100mg Tablet); and depressive symptoms, using the Beck Depression Score. Blinding of the participants will be evaluated using a Validation of Blinding Questionnaire at the end of the treatment period.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Jerusalem, Israel, 91031
- Shaare Zedek Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients of either gender
- Age 18 years and older
- Scheduled for lower single limb amputation (above or below knee)
- Ability to comply with study protocol
Exclusion Criteria:
- Patients requiring limb amputation due to trauma
- Patients displaying symptoms of overt Axis-1 psychopathology such as Schizophrenia or Substance Abuse
- Inability to comply with the study protocol
- Previous experience with acupuncture treatment; current use of complementary or alternative medical treatments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 1
true acupuncture
|
2 treatments/week for 4 weeks
|
|
Placebo Comparator: 2
placebo/sham acupuncture
|
2 treatments/week for 4 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To study the effect of acupuncture on phantom limb pain at 4 weeks post-amputation
Time Frame: 4 weeks
|
4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
To study the effect of acupuncture on phantom limb pain at 3 months post-amputation
Time Frame: 3 months
|
3 months
|
|
To study the effect of acupuncture on stump pain at 4 weeks post-amputation
Time Frame: 4 weeks
|
4 weeks
|
|
To study the effect of acupuncture on analgesic use (Tramadol 100mg) during the first 4 weeks post-amputation
Time Frame: 4 weeks
|
4 weeks
|
|
To study the effect of acupuncture on parameters of depression (using the Beck Depression Score) at 4 weeks and 3 months post-amputation
Time Frame: 4 weeks and 3 months
|
4 weeks and 3 months
|
|
To study the safety of acupuncture treatment in patients following amputation with phantom limb pain
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Noah Samuels, M.D., Shaare Zedek Medical Center, Jerusalem, Israel
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACP.PLP.10.06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.